UBS Group’s Core Scientific Inc Tranche 2 Warrants CORZZ Stock Holding History

UBS Group’s Portfolio CORZZ Stock Details CORZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.3K	Buy	756 +544	+257%	+$9.27K	﹤0.01%	8315
2025 Q4	$3.08K	Sell	212 -251	-54%	-$4.38K	﹤0.01%	9116
2025 Q3	$8.31K	Buy	463 +268	+137%	+$3.93K	﹤0.01%	8669
2025 Q2	$3.36K	Sell	195 -7,621	-98%	-$75.9K	﹤0.01%	9364
2025 Q1	$56.1K	Buy	7,816 +5,318	+213%	+$60.3K	﹤0.01%	7499
2024 Q4	$35K	Buy	2,498 +1,281	+105%	+$18.9K	﹤0.01%	7516
2024 Q3	$14.3K	Sell	1,217 -9,077	-88%	-$93.5K	﹤0.01%	7548
2024 Q2	$89.5K	Buy	+10,294	New	+$39.3K	﹤0.01%	6257

Other funds holding CORZZ

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.48B AUM 24.99% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group's CORZZ Position: Q1 2026 in Review

UBS Group increased its Core Scientific Inc Tranche 2 Warrants (CORZZ) stake by 257% in Q1 2026, buying an estimated $9.27K and bringing the position to 756 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #8315.

UBS Group first reported a position in CORZZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $89.5K in Q2 2024. 29 funds tracked by Wall St. Rank hold CORZZ as of Q1 2026.

UBS Group held 756 shares of Core Scientific Inc Tranche 2 Warrants worth $11.3K as of Q1 2026.
UBS Group bought 544 Core Scientific Inc Tranche 2 Warrants shares in Q1 2026, an estimated $9.27K.
Core Scientific Inc Tranche 2 Warrants made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8315 holding.
UBS Group first reported a position in Core Scientific Inc Tranche 2 Warrants in Q2 2024 and has held it in 8 quarters since.
UBS Group's Core Scientific Inc Tranche 2 Warrants position peaked at $89.5K in Q2 2024.
29 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 2 Warrants as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.